Search

Your search keyword '"Protein Aggregates drug effects"' showing total 1,384 results

Search Constraints

Start Over You searched for: Descriptor "Protein Aggregates drug effects" Remove constraint Descriptor: "Protein Aggregates drug effects"
1,384 results on '"Protein Aggregates drug effects"'

Search Results

1301. Investigating the effects of plasma pretreatment on the formation of ordered aggregates of lysozyme.

1302. Rationally designed peptidomimetic modulators of aβ toxicity in Alzheimer's disease.

1303. The cleavage pattern of TDP-43 determines its rate of clearance and cytotoxicity.

1304. New roles of glycosaminoglycans in α-synuclein aggregation in a cellular model of Parkinson disease.

1305. Effects of tau domain-specific antibodies and intravenous immunoglobulin on tau aggregation and aggregate degradation.

1306. Ligand-receptor interaction catalyzes the aggregation of small molecules to induce cell necroptosis.

1307. Intermolecular disulfide bond formation promotes immunoglobulin aggregation: investigation by fluorescence correlation spectroscopy.

1308. A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells.

1309. Modeling the Aggregation Propensity and Toxicity of Amyloid-β Variants.

1310. Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease.

1311. Inhibitory effect of copper nanoparticles on rosin modified surfactant induced aggregation of lysozyme.

1312. The Role of Aggregates of Therapeutic Protein Products in Immunogenicity: An Evaluation by Mathematical Modeling.

1313. Loss of TDP-43 Inhibits Amyotrophic Lateral Sclerosis-Linked Mutant SOD1 Aggresome Formation in an HDAC6-Dependent Manner.

1314. Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease.

1315. Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies.

1316. The effect of glycerol and 2-propanol on the molecular aggregation of collagen in solution.

1317. The marine n-3 PUFA DHA evokes cytoprotection against oxidative stress and protein misfolding by inducing autophagy and NFE2L2 in human retinal pigment epithelial cells.

1318. Tetrahydroxystilbene glucoside ameliorates memory and movement functions, protects synapses and inhibits α-synuclein aggregation in hippocampus and striatum in aged mice.

1319. Anti-fibrillation potency of caffeic acid against an antidepressant induced fibrillogenesis of human α-synuclein: Implications for Parkinson's disease.

1320. Deubiquitinase inhibition by WP1130 leads to ULK1 aggregation and blockade of autophagy.

1321. Identification of peptides in human Hsp20 and Hsp27 that possess molecular chaperone and anti-apoptotic activities.

1322. Non-fluorinated cosolvents: A potent amorphous aggregate inducer of metalloproteinase-conalbumin (ovotransferrin).

1323. Inhibition of β-amyloid Aggregation By Albiflorin, Aloeemodin And Neohesperidin And Their Neuroprotective Effect On Primary Hippocampal Cells Against β-amyloid Induced Toxicity.

1324. A Novel Tetradentate Ruthenium(II) Complex Containing Tris(2- Pyridylmethyl)amine (tpa) As An Inhibitor Of Beta-amyloid Fibrillation.

1325. Pyranopyrazolotacrines as nonneurotoxic, Aβ-anti-aggregating and neuroprotective agents for Alzheimer's disease.

1326. Inhibitory Activity Of Curcumin Derivatives Towards Metal-free And Metal-induced Amyloid-β Aggregation.

1327. Syntheses And Evaluation Of Asymmetric Curcumin Analogues As Potential Multifunctional Agents For The Treatment Of Alzheimer's Disease.

1328. Experimental and computational investigation of the effect of hydrophobicity on aggregation and osteoinductive potential of BMP-2-derived peptide in a hydrogel matrix.

1329. Magnetic Cross-Linked Enzyme Aggregates (mCLEAs) of Candida antarctica lipase: an efficient and stable biocatalyst for biodiesel synthesis.

1330. Identification of an allosteric small-molecule inhibitor selective for the inducible form of heat shock protein 70.

1331. Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma.

1332. Epigallocatechin-3-gallate and tetracycline differently affect ataxin-3 fibrillogenesis and reduce toxicity in spinocerebellar ataxia type 3 model.

1333. Proteasome dysfunction induces muscle growth defects and protein aggregation.

1334. Noninvasive bioluminescence imaging of α-synuclein oligomerization in mouse brain using split firefly luciferase reporters.

1335. A cyclic KLVFF-derived peptide aggregation inhibitor induces the formation of less-toxic off-pathway amyloid-β oligomers.

1336. Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer's disease.

1337. Differential effect of HDAC3 on cytoplasmic and nuclear huntingtin aggregates.

1338. Small bifunctional chelators that do not disaggregate amyloid β fibrils exhibit reduced cellular toxicity.

1339. Anti-amyloidogenic property of human gastrokine 1.

1340. Selective modulation of plasmodial Hsp70s by small molecules with antimalarial activity.

1341. Cystatin C protects neuronal cells against mutant copper-zinc superoxide dismutase-mediated toxicity.

1342. Suramin inhibits Hsp104 ATPase and disaggregase activity.

1343. DNA methylation effects on tetra-nucleosome compaction and aggregation.

1344. Effects of secondary metabolite extract from Phomopsis occulta on β-amyloid aggregation.

1345. Diphenyl ethers from Aspergillus sp. and their anti-Aβ₄₂ aggregation activities.

1346. Peptide-based treatment strategies for cataract.

1347. A GCase chaperone improves motor function in a mouse model of synucleinopathy.

1348. Identification of aggregation inhibitors of the human antibody light chain repertoire by phage display.

1349. Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties.

1350. Molecular tethering effect of C-terminus of amyloid peptide aβ42.

Catalog

Books, media, physical & digital resources